123 related articles for article (PubMed ID: 16052436)
1. Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment.
Jackman DM; Chirieac LR; Jänne PA
Semin Respir Crit Care Med; 2005 Jun; 26(3):342-52. PubMed ID: 16052436
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
[TBL] [Abstract][Full Text] [Related]
3. [Other thoracic cancers. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar carcinoma feature: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S196-202. PubMed ID: 18971846
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.
Read WL; Page NC; Tierney RM; Piccirillo JF; Govindan R
Lung Cancer; 2004 Aug; 45(2):137-42. PubMed ID: 15246183
[TBL] [Abstract][Full Text] [Related]
6. [Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S158-16S163. PubMed ID: 17268353
[TBL] [Abstract][Full Text] [Related]
7. [Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S165-70. PubMed ID: 18235410
[TBL] [Abstract][Full Text] [Related]
8. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
[TBL] [Abstract][Full Text] [Related]
9. Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors.
Bonomi PD; Buckingham L; Coon J
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4606-12. PubMed ID: 17671150
[TBL] [Abstract][Full Text] [Related]
10. A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.
Johal BS; Laskin J
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1411-9. PubMed ID: 17069526
[TBL] [Abstract][Full Text] [Related]
11. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.
Gandara DR; West H; Chansky K; Davies AM; Lau DH; Crowley J; Gumerlock PH; Hirsch FR; Franklin WA
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4205s-4209s. PubMed ID: 15217959
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
[TBL] [Abstract][Full Text] [Related]
13. Bronchioloalveolar carcinoma: the case for two diseases.
Garfield DH; Cadranel J; West HL
Clin Lung Cancer; 2008 Jan; 9(1):24-9. PubMed ID: 18282354
[TBL] [Abstract][Full Text] [Related]
14. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
[TBL] [Abstract][Full Text] [Related]
15. Small peripheral pulmonary adenocarcinoma: morphologic and molecular update.
Weydert JA; Cohen MB
Adv Anat Pathol; 2007 Mar; 14(2):120-8. PubMed ID: 17471118
[TBL] [Abstract][Full Text] [Related]
16. Bronchioloalveolar carcinoma: the "changing face of lung cancer".
Gandara DR
Clin Lung Cancer; 2006 Mar; 7(5):299. PubMed ID: 16640799
[No Abstract] [Full Text] [Related]
17. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Jänne PA; Johnson BE
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4416s-4420s. PubMed ID: 16857820
[TBL] [Abstract][Full Text] [Related]
18. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G
Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of bronchioloalveolar carcinoma.
Falk RT; Pickle LW; Fontham ET; Greenberg SD; Jacobs HL; Correa P; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):339-44. PubMed ID: 1339048
[TBL] [Abstract][Full Text] [Related]
20. Bronchioloalveolar carcinoma: a review.
Raz DJ; He B; Rosell R; Jablons DM
Clin Lung Cancer; 2006 Mar; 7(5):313-22. PubMed ID: 16640802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]